Deep learning and ensemble stacking technique for differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration

Código QR

Deep learning and ensemble stacking technique for differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration

Abstract Polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD) share some similarity in clinical imaging manifestations. However, their disease entity and treatment strategy as well as visual outcomes are very different. To distinguish these two vision-threa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu-Bai Chou, Chung-Hsuan Hsu, Wei-Shiang Chen, Shih-Jen Chen, De-Kuang Hwang, Yi-Ming Huang, An-Fei Li, Henry Horng-Shing Lu
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/e4e28f29a53b46599fddd262e0dc345d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Ki Won Jin, et al.
Publicado: (2021)

Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
por: Hidetaka Matsumoto, et al.
Publicado: (2021)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
por: Bhoomibunchoo C, et al.
Publicado: (2017)

Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study
por: Daniel Shu Wei Ting, et al.
Publicado: (2017)

Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography
por: Georges Azar, et al.
Publicado: (2021)

Choroidal excavation with polypoidal choroidal vasculopathy: a case report
por: Kobayashi W, et al.
Publicado: (2012)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
por: Azuma K, et al.
Publicado: (2018)

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy
por: Te-An Wang, et al.
Publicado: (2021)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
por: Dimitrios A Karagiannis, et al.
Publicado: (2009)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
por: Miura M, et al.
Publicado: (2013)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
por: Arakawa A, et al.
Publicado: (2017)

Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern
por: Alshahrani ST, et al.
Publicado: (2014)

The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes
por: Huajui Wu, et al.
Publicado: (2021)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri S, et al.
Publicado: (2021)

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa
por: Oluleye TS, et al.
Publicado: (2013)

Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
por: Joo Young Kim, et al.
Publicado: (2021)

Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
por: Matsuo Y, et al.
Publicado: (2021)

Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
por: Nemoto R, et al.
Publicado: (2012)

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
por: Ratanasukon M, et al.
Publicado: (2018)

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
por: Kitahashi M, et al.
Publicado: (2014)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
por: Mario R Romano, et al.
Publicado: (2010)

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita M, et al.
Publicado: (2014)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
por: Sakurai M, et al.
Publicado: (2014)

Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography
por: Shang-Te Ma, et al.
Publicado: (2021)

Association Between the Degree of Inclusion of Components Identified on Fluorescein or Indocyanine Green Angiography in Target Spots and Relapse of Exudate in Eyes with Polypoidal Choroidal Vasculopathy and Typical Age-Related Macular Degeneration After Photodynamic Therapy
por: Yoshida I, et al.
Publicado: (2021)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
por: Sheng-Chu Chi, et al.
Publicado: (2021)

Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
por: Min Zhao, et al.
Publicado: (2019)

Management of neovascular age-related macular degeneration: Taiwan expert consensus
por: Ling Yeung, et al.
Publicado: (2021)

Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
por: Ling Yeung, et al.
Publicado: (2021)

Major single nucleotide polymorphisms in polypoidal choroidal vasculopathy: a comparative analysis between Thai and other Asian populations
por: Chantaren P, et al.
Publicado: (2012)

Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
por: Balaratnasingam C, et al.
Publicado: (2015)

Distinguishing retinal angiomatous proliferation from polypoidal choroidal vasculopathy with a deep neural network based on optical coherence tomography
por: Daniel Duck-Jin Hwang, et al.
Publicado: (2021)

Histology of neovascular myopic macular degeneration
por: Shefali B. Jonas, et al.
Publicado: (2021)

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
por: I-Chia Liang, et al.
Publicado: (2021)

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Roberto Gallego-Pinazo, et al.
Publicado: (2011)

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Taeyoung Koo, et al.
Publicado: (2018)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008)

Monozygotic twins with polypoidal choroidal vasuculopathy
por: Shigeki Machida, et al.
Publicado: (2010)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Pukhraj Rishi, et al.
Publicado: (2011)

Systematic review and meta-analysis of the association between complement factor H I62V polymorphism and risk of polypoidal choroidal vasculopathy in Asian populations.
por: Zhao-Yang Wang, et al.
Publicado: (2014)